List of Excipients in API bempedoic acid
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bempedoic acid
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Esperion Therapeutics Inc | NEXLETOL | bempedoic acid | 72426-118 | HYDROXYPROPYL CELLULOSE | 2025-12-03 |
Esperion Therapeutics Inc | NEXLETOL | bempedoic acid | 72426-118 | LACTOSE MONOHYDRATE | 2025-12-03 |
Esperion Therapeutics Inc | NEXLETOL | bempedoic acid | 72426-118 | MAGNESIUM STEARATE | 2025-12-03 |
Esperion Therapeutics Inc | NEXLETOL | bempedoic acid | 72426-118 | MICROCRYSTALLINE CELLULOSE 101 | 2025-12-03 |
Esperion Therapeutics Inc | NEXLETOL | bempedoic acid | 72426-118 | POLYETHYLENE GLYCOL | 2025-12-03 |
Esperion Therapeutics Inc | NEXLETOL | bempedoic acid | 72426-118 | POLYVINYL ALCOHOL | 2025-12-03 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for bempedoic acid
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
bempedoic acid drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
bempedoic acid drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
bempedoic acid drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
bempedoic acid drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
bempedoic acid drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
bempedoic acid drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
bempedoic acid drug variants containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
bempedoic acid drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
bempedoic acid drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
bempedoic acid drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
bempedoic acid drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
bempedoic acid drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
bempedoic acid drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
bempedoic acid drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
bempedoic acid drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
bempedoic acid drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Esperion Therapeutics Inc | bempedoic acid | 72426-118 |
Esperion Therapeutics Inc | bempedoic acid and ezetimibe | 72426-818 |
>Company | >Ingredient | >NDC |
bempedoic acid drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.